Literature DB >> 9869591

A 5-year surveillance study of 44,691 isolates of Haemophilus influenzae project Beta-Alert 1993-1997.

A Derecola1, D L Butler, R L Kaplan, L A Miller, J A Poupard.   

Abstract

Beta-Alert is a surveillance program developed in 1993 to monitor the percentage of beta-lactamase-producing Haemophilus influenzae isolates obtained from specimens submitted to regional commercial laboratories. The results of this study demonstrate that levels of beta-lactamase producers have remained between 31 and 38% in the United States over the past 5 years.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9869591      PMCID： PMC89046     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  6 in total

1.  Analysis of oral antibiotic treatment that failed to prevent the development of Haemophilus influenzae meningitis: consequences on mortality.

Authors:  H Dabernat; A Scheimberg; J Astruc
Journal:  J Antimicrob Chemother       Date:  1996-10       Impact factor: 5.790

2.  A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United States.

Authors:  R N Jones; M R Jacobs; J A Washington; M A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  1997-03       Impact factor: 2.803

3.  Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.

Authors:  G V Doern; A B Brueggemann; G Pierce; H P Holley; A Rauch
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

Review 4.  The antibiotic treatment of acute otitis media and sinusitis in children.

Authors:  R Cohen
Journal:  Diagn Microbiol Infect Dis       Date:  1997 Jan-Feb       Impact factor: 2.803

5.  A survey of beta-lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolates.

Authors:  S F Rittenhouse; L A Miller; R L Kaplan; G H Mosely; J A Poupard
Journal:  Diagn Microbiol Infect Dis       Date:  1995-04       Impact factor: 2.803

Review 6.  Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract.

Authors:  G V Doern
Journal:  Am J Med       Date:  1995-12-29       Impact factor: 4.965
  6 in total
  3 in total

1.  Multicenter surveillance of antimicrobial resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998-1999 respiratory season.

Authors:  P R Hsueh; Y C Liu; J M Shyr; T L Wu; J J Yan; J J Wu; H S Leu; Y C Chuang; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States.

Authors:  Kris P Heilmann; Cassie L Rice; Ashley L Miller; Norma J Miller; Susan E Beekmann; Michael A Pfaller; Sandra S Richter; Gary V Doern
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

3.  Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx.

Authors:  Jennelle M Kyd; Allan W Cripps; Laura A Novotny; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.